Cardiac complications during waiting for elective coronary artery bypass graft surgery: Incidence, temporal distribution and predictive factors

European Journal of Cardio-thoracic Surgery

Volumn 25, Issue 2, 2004, Pages 196-202

  Cesena, Fernando Henpin Yue ^a   Favarato, Desiderio ^a   Machado César, Luiz Antônio ^a   Almeida De Oliveira, Sérgio ^a   Lemos Da Luz, Protásio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Coronary artery bypass; Coronary disease; Waiting lists

Indexed keywords

ANTIDIABETIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; NITRATE; TRIACYLGLYCEROL;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DATA ANALYSIS; DIABETES MELLITUS; FEMALE; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HOSPITAL ADMISSION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PATIENT REFERRAL; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; CORONARY ARTERY BYPASS; CORONARY DISEASE; DEATH, SUDDEN; DEATH, SUDDEN, CARDIAC; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; RISK FACTORS; SURGICAL PROCEDURES, ELECTIVE; TIME FACTORS; TRIGLYCERIDES; VENTRICULAR DYSFUNCTION, LEFT; WAITING LISTS;

EID: 1642493795     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2003.11.004     Document Type: Article

References (25)

1. Koomen E.M., Hutten B.A., Kelder J.C., Redekop W.K., Tijssen J.G., Kingma J.H. Morbidity and mortality in patients waiting for coronary artery bypass surgery. Eur J Cardiothorac Surg. 19:2001;260-265.
2. Silber S., Muhling H., Dorr R., Zindler G., Preuss A., Stumpfl A. Waiting times and death on the waiting list for coronary artery bypass operation. Experiences in Munich with over 1,000 patients. Herz. 21:1996;389-396.
3. Morgan C.D., Sykora K., Naylor C.D. Analysis of deaths while waiting for cardiac surgery among 29,293 consecutive patients in Ontario, Canada. The Steering Committee of the Cardiac Care Network of Ontario. Heart. 79:1998;345-349.
4. Ray A.A., Buth K.J., Sullivan J.A., Johnstone D.E., Hirsch G.M. Waiting for cardiac surgery: results of a risk-stratified queuing process. Circulation. 104:(Suppl 1):2001;I92-I98.
5. Jackson N.W., Doogue M.P., Elliott J.M. Priority points and cardiac events while waiting for coronary bypass surgery. Heart. 81:1999;367-373.
6. Seddon M.E., French J.K., Amos D.J., Ramanathan K., McLaughlin S.C., White H.D. Waiting times and prioritisation for coronary artery bypass surgery in New Zealand. Heart. 81:1999;586-592.
7. Bernstein S.J., Rigter H., Brorsson B., Hilborne L.H., Leape L.L., Meijler A.P., Scholma J.K., Nord A.S. Waiting for coronary revascularization: a comparison between New York State. The Netherlands and Sweden. Health Policy. 42:1997;15-27.
8. Haddad N., Bittar O.J., Pereira A.A., da Silva M.B., Amato V.L., Farsky P.S., Ramos A.I., Sampaio M., Almeida T.L., Armaganijan D., Sousa J.E. Consequences of the prolonged waiting time for patient candidates for heart surgery. Arq Bras Cardiol. 78:2002;452-458.
9. Koivula M., Paunonen-Ilmonen M., Tarkka M.T., Tarkka M., Laippala P. Fear and anxiety in patients awaiting coronary artery bypass grafting. Heart Lung. 30:2001;302-311.
10. Deanfield J.E., Shea M., Kensett M., Horlock P., Wilson R.A., de Landsheere C.M., Selwyn A.P. Silent myocardial ischaemia due to mental stress. Lancet. 2:1984;1001-1005.
11. Ringqvist I., Fisher L.D., Mock M., Davis K.B., Wedel H., Chaitman B.R., Passamani E., Russell R.O. Jr, Alderman E.L., Kouchoukas N.T., Kaiser G.C., Ryan T.J., Killip T., Fray D. Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). J Clin Invest. 71:1983;1854-1866.
12. Naylor C.D., Baigrie R.S., Goldman B.S., Basinski A. Assessment of priority for coronary revascularisation procedures. Revascularisation Panel and Consensus Methods Group. Lancet. 335:1990;1070-1073.
13. Bengtson A., Karlsson T., Hjalmarson A., Herlitz J. Complications prior to revascularization among patients waiting for coronary artery bypass grafting and percutaneous transluminal coronary angioplasty. Eur Heart J. 17:1996;1846-1851.
14. Beanlands R.S., Hendry P.J., Masters R.G., deKemp R.A., Woodend K., Ruddy T.D. Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging. Circulation. 98:1998;II51-II56.
15. Conti C.R., Geller N.L., Knatterud G.L., Forman S.A., Pratt C.M., Pepine C.J., Sopko G. Anginal status and prediction of cardiac events in patients enrolled in the asymptomatic cardiac ischemia pilot (ACIP) study. ACIP investigators. Am J Cardiol. 79:1997;889-892.
16. Califf R.M., Mark D.B., Harrell F.E. Jr, Hlatky M.A., Lee K.L., Rosati R.A., Pryor D.B. Importance of clinical measures of ischemia in the prognosis of patients with documented coronary artery disease. J Am Coll Cardiol. 11:1988;20-26.
17. Spertus J.A., Jones P., McDonell M., Fan V., Fihn S.D. Health status predicts long-term outcome in outpatients with coronary disease. Circulation. 106:2002;43-49.
18. Byrne C.D. Triglyceride-rich lipoproteins: are links with atherosclerosis mediated by a procoagulant and proinflammatory phenotype? Atherosclerosis. 145:1999;1-15.
19. Proctor S.D., Mamo J.C. Retention of fluorescent-labelled chylomicron remnants within the intima of the arterial wall-evidence that plaque cholesterol may be derived from post-prandial lipoproteins. Eur J Clin Invest. 28:1998;497-503.
20. Bae J.H., Bassenge E., Kim K.B., Kim Y.N., Kim K.S., Lee H.J., Moon K.C., Lee M.S., Park K.Y., Schwemmer M. Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress. Atherosclerosis. 155:2001;517-523.
21. Rosenson R.S., Shott S., Tangney C.C. Hypertriglyceridemia is associated with an elevated blood viscosity Rosenson: triglycerides and blood viscosity. Atherosclerosis. 161:2002;433-439.
22. Isomaa B., Almgren P., Tuomi T., Forsen B., Lahti K., Nissen M., Taskinen M.R., Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 24:2001;683-689.
23. Krauss R.M. Triglycerides and atherogenic lipoproteins: rationale for lipid management. Am J Med. 105:(1A):1998;58S-62S.
24. Coresh J., Kwiterovich P.O. Jr, Smith H.H., Bachorik P.S. Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women. J Lipid Res. 34:1993;1687-1697.
25. Chester M., Chen L., Kaski J.C. Identification of patients at high risk for adverse coronary events while awaiting routine coronary angioplasty. Br Heart J. 73:1995;216-222.